
Eyam Health develops next-generation vaccines and immunotherapeutics that aim to be safe, effective, and low-dose for infectious disease prevention and treatment. The company operates as a platform biotech, using technologies such as self-amplifying RNA and DNA alongside AI and machine learning to design and optimize candidates, and offers product and licensing models. Notable platform products include Gemini and Jennerator, which enable customizable vaccine and therapeutic design and delivery. Eyam targets healthcare organizations and developers seeking rapid, scalable biologic solutions for emerging infectious threats.

Eyam Health develops next-generation vaccines and immunotherapeutics that aim to be safe, effective, and low-dose for infectious disease prevention and treatment. The company operates as a platform biotech, using technologies such as self-amplifying RNA and DNA alongside AI and machine learning to design and optimize candidates, and offers product and licensing models. Notable platform products include Gemini and Jennerator, which enable customizable vaccine and therapeutic design and delivery. Eyam targets healthcare organizations and developers seeking rapid, scalable biologic solutions for emerging infectious threats.